Articles issus de: NEJM, Lancet, Lancet ID, Eurosurveillance, EID, WER, MMWR.......
Revues diverses
Am J Respir Crit Care Med.Lung Pathology in Fatal Novel Human Influenza A (H1N1) Infection.Mauad
T
Am J Roentgenol
Chest
radiographic and CT findings in novel swine-origin influenza A (H1N1)
virus (S-OIV) infection. Agarwal PP
Am
J Transplant.
Guidance
on Novel Influenza A/H1N1 in Solid Organ Transplant Recipients. Kumar
D. AST Infectious Diseases
Community of Practice and Transplant Infectious Diseases Section of TTS.
Ann Intern Med. 2009 Oct 5.
Effectiveness and Cost-Effectiveness of Vaccination Against Pandemic
Influenza
(H1N1)
2009. Khazeni N
Antiviral Res. 2009 Dynamics of antiviral resistant influenza viruses in the Netherlands, 2005-2008. Jonges M [virus saisonnier]
Arch Dis Child.
Pandemic
(H1N1) 2009: A clinical spectrum
in the general paediatric population.
Larcombe PJ
Blood
How we treat influenza in patients with hematologic malignancies. Casper C
Chest
Clinical
findings and demographic factors associated with intensive care unit
admission in Utah due to 2009 novel influenza A (H1N1) infection.
Miller RR 3rdCID
Clinical
Effectiveness of Oseltamivir and Zanamivir for Treatment of Influenza A
Virus Subtype H1N1 with the H274Y Mutation: A Japanese, Multicenter
Study of the 2007-2008 and 2008-2009 Influenza Seasons. Kawai N
Economic Value of Seasonal and Pandemic Influenza Vaccination during Pregnancy. Beigi RH
Notes
from the Field: Outbreak of 2009 Pandemic Influenza A (H1N1) Virus at a
Large Public University in Delaware, April-May 2009. Iuliano AD
Clinical
and Epidemiologic Characteristics of an Outbreak of Novel H1N1 (Swine
Origin) Influenza A Virus among United States Military Beneficiaries. Crum-Cianflone NF
CMAJ.
Modelling mitigation strategies for pandemic (H1N1) 2009. Gojovic MZ
Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women (pdf)
Investigation of the first cases of human-to-human infection with the new swine-origin influenza A (H1N1) virus in Canada. Cutler J
Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza.O'Riordan S,
Estimated
epidemiologic parameters and morbidity associated with pandemic H1N1
influenza.Tuite AR
Crit Care. 2009 Sep 11;13(5):R148. Intensive care adult
patients with severe respiratory failure caused by Influenza A (H1N1)v
in Spain. Rello J et al.Crit
Care Med.
Infection
control in mass respiratory failure: Preparing to respond to H1N1.
Daugherty EL
Drug SafVaccines and Guillain-Barré syndrome.Haber P
Epidemiol Infect 24/8: Influenza epidemiology and characterization of influenza viruses in patients seeking treatment for acute fever in Cambodia. P. J. BLAIR
Eur J Radiol. High-resolution
computed tomography findings from adult patients with Influenza A
(H1N1) virus-associated pneumonia. Marchiori E.
Hong
Kong Med J. 2009 Oct;15(5):381-4.The first novel influenza
A (H1N1)
fatality despite antiviral treatment and extracorporeal membrane
oxygenation in Hong Kong. Liong T
Intens Care Med
:Non-invasive management of acute respiratory distress syndrome related to Influenza A (H1N1) virus pneumonia in a pregnant woman
Michel Djibré
H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment.Quispe-Laime AM
JAC
Swine flu and antibiotics Barlow GD
J Clin Virol. 2009 Sep 5:
Detection of an oseltamivir-resistant pandemic influenza A/H1N1 virus in Hong Kong. Leung TW, .
Person-to-person transmission of oseltamivir-resistant influenza A/H1N1 viruses in two households; Germany 2007/08. Duwe S
Performance
of laboratory diagnostics for the detection of influenza A(H1N1)v virus
as correlated with the time after symptom onset and viral load.
Cheng PK
J Infect. 2009 Sep 9 (lettre): .Systematic
telephone triage of possible 'Swine' influenza leads to potentially
serious misdiagnosis of infectious diseases. Payne R, et al.
J Med Virol
Viral
load in patients infected with pandemic H1N1 2009 influenza A virus.
To KK.
Med J Aust.
Med
Mal Infect.
2H1N1
Flu:
Another possible diagnosis. Cazanave C
2009 Premiers cas de transmission secondaire en France du nouveau virus grippal d’origine porcine A(H1N1)v Jeannot AC
PLOS currents influenza: Targeted
vs. systematic early antiviral treatment against A(H1N1)v influenza
with neuraminidase inhibitors in patients with influenza-like symptoms:
Clinical and economic impact. Sylvie Deuffic-Burban
PNAS
Pre-existing immunity against swine-origin H1N1 influenza
viruses in the general human population. Greenbaum JA
Dating the emergence of pandemic influenza viruses.Smith GJ, et al.
Science. 2009 Sep
10. The
Transmissibility and Control of Pandemic Influenza A (H1N1) Virus.
Yang et al
Vaccine.Exposure
to MF59-adjuvanted influenza vaccines during pregnancy-A retrospective
analysis. Tsai T
BMJ
What
can we learn from observational studies of oseltamivir to treat
influenza in healthy adults? Freemantle N
2009;339:b3928. Partial
protection of seasonal trivalent inactivated vaccine against novel
pandemic influenza A/H1N1 2009: case-control study in Mexico City.
Lourdes Garcia-Garcia22/9: Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review Tom Jefferson
27/8: Monitoring the emergence of community transmission of
influenza A/H1N1 2009 in England: a cross sectional opportunistic
survey of self sampled telephone callers to NHS Direct. AJ Elliot [Full text]
10/8: Neuraminidase
inhibitors for treatment and prophylaxis of influenza in children:
systematic review and meta-analysis of randomised controlled trials. Shun-Shin M
Neuraminidase
inhibitors for preventing and treating influenza in healthy adults:
systematic review and meta-analysis Tom Jefferson
Factors Associated With Death or Hospitalization Due to Pandemic 2009 Influenza A(H1N1) Infection in California Louis JK Abstract
Critically
Ill Patients With 2009 Influenza A(H1N1) Infection in Canada Published
October 12, 2009.
Critically
Ill Patients With 2009 Influenza A(H1N1) in Mexico Published
October 12, 2009.
Extracorporeal
Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory
Distress Syndrome Published October 12, 2009.
Preparing
for the Sickest Patients With 2009 Influenza A(H1N1) Published
October 12, 2009.Surgical Mask vs N95 Respirator for Preventing Influenza Among Health Care Workers Published October 1, 2009.
Respiratory Protection Against Influenza Published October 1, 2009.
Serologic
Cross-Reactivity with Pandemic (H1N1) 2009 Virus in Pigs, Europe C.S.
Kyriakas
Hospitalizations
for Pandemic (H1N1) 2009 among Maori and Pacific Islanders, New Zealand
A. Verrall
Pandemic
(H1N1) 2009 Surveillance and Prevalence of Seasonal Influenza, SingaporeY.-S.
Leo et al.
Severe
Pneumonia Associated with Pandemic (H1N1) 2009 Outbreak, San Luis
Potosí, Mexico A. Gómez-Gómez
Epidemiology
of Travel-associated Pandemic (H1N1) 2009 Infection in 116 Patients,
Singapore P. Mukherjee et al.
Laboratory
Surge Response to Pandemic (H1N1) 2009 Outbreak, New York City
Metropolitan Area, USA J.M. Crawford et al.
Pandemic Influenza as 21st Century Urban Public Health Crisis D.M. Bell et al.
Genomic Signatures of Influenza A Pandemic (H1N1) 2009 Virus G.-W. Chen and S.-R. Shih et al.
Cost-effectiveness Analysis of Hospital Infection Control Response to an Epidemic Respiratory Virus Threat Y.Y. Dan et al.
Respiratory Infection in Institutions during Early Stages of Pandemic (H1N1) 2009, Canada A. Marchand-Austin et al.
Outbreak of Antiviral Drug–Resistant Influenza A in Long-Term Care Facility, Illinois, USA, 2008 N.J. Dharan
Oseltamivir-Resistant Influenza A Pandemic (H1N1) 2009 Virus, Hong Kong, China H. Chen
Extracorporeal Membrane Oxygenation for Pandemic (H1N1) 2009 M. Firstenberg
Respiratory Disease in Adults during Pandemic (H1N1) 2009 Outbreak, Argentina C. Zala
Evidence-based Tool for Triggering School Closures during Influenza Outbreaks, Japan A. Sasaki et al.
Antiviral Drugs for Treatment of Patients Infected with Pandemic (H1N1) 2009 Virus D.M. Hartley et al..
Oseltamivir
Prophylaxis Strategies to Prevent Influenza in Nursing Homes C.
van den Dool et al.
Excess Deaths and Immunoprotection during 1918–1920 Influenza Pandemic, Taiwan Y.-H. Hsieh
Preexisting Immunity to Pandemic (H1N1) 2009Z. Xing and C.J. Cardona
Serologic Survey of Pandemic (H1N1) 2009 Virus, Guangxi Province, ChinaH. Chen et al.
Influenza
(H1N1) 2009 Outbreak and School Closure, Osaka Prefecture, Japan R.
Kawaguchi et al.A Model-based Assessment of Oseltamivir Prophylaxis Strategies to Prevent Influenza in Nursing Homes C. van den Dool et al.
Lack of Airborne Transmission during Outbreak of Pandemic (H1N1) 2009 among Tour Group Members, China, June 2009 K. Han et al.
Poor Clinical Sensitivity of Rapid Antigen Test for Influenza A Pandemic (H1N1) 2009 Virus J.F. Drexler et al.
Genomic Diversity of Oseltamivir-Resistant Influenza Virus A (H1N1), Luxembourg, 2007–08 N.A. Gerloff et al.
Use of Revised International Health Regulations during Influenza A (H1N1) Epidemic, 2009 R. Katz et al.
Strategy to Enhance Influenza Surveillance Worldwide J.R. Ortiz et al.
Oseltamivir- and Amantadine-Resistant Influenza Viruses A (H1N1) P.K.C. Cheng et al. [virus saisonnier, pas le pandémique]
BMC med
Post-exposure
prophylaxis during pandemic outbreaks. Moghadas SM,
2009 Sep 10 Seasonal
transmission potential and activity peaks of the new influenza A(H1N1):
a Monte Carlo likelihood analysis based on human mobility.
Balcan D
et al2009 Sep 3;7(1):43. Modelling
the progression of pandemic influenza A (H1N1) in Vietnam and the
opportunities for reassortment with other influenza viruses.
Boni MF
2009 Pandemic Flu: Lessons From the Frontlines Modeling influenza epidemics and pandemics: insights into the future of swine flu (H1N1). Coburn BJ, Wagner BG, Blower S. PLoS
PLoS One.Adaptive
vaccination strategies to mitigate pandemic influenza: Mexico as a case
study.Chowell G
2009 Sep 9 Use
of cumulative incidence of novel influenza A/H1N1 in foreign travelers
to estimate lower bounds on cumulative incidence in Mexico.
Lipsitch M et al
2009 Jun 25;4(6):e6051. Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome. Hanshaoworakul W, et al.
PLoS Med. The
severity of pandemic H1N1 influenza in the United States, from April to
July 2009: a Bayesian analysis. Presanis
AM
Intent
to Receive Influenza A (H1N1) 2009 Monovalent and Seasonal Influenza
Vaccines --- Two Counties, North Carolina, August 2009
Safety of Influenza A (H1N1) 2009 Monovalent Vaccines
--- United States, October 1--November 24, 2009
Update:
Influenza Activity --- United States, August 30--October 31, 2009
Effectiveness
of 2008--09 Trivalent Influenza Vaccine Against 2009 Pandemic Influenza
A (H1N1) --- United States, May--June 2009
introduction
and Transmission of 2009 Pandemic Influenza A (H1N1) Virus --- Kenya,
June--July 2009
9/10: Update on Influenza A (H1N1) 2009 Monovalent Vaccines
29/9 : Bacterial
Coinfections in Lung Tissue Specimens from Fatal Cases of 2009 Pandemic
Influenza A (H1N1) --- United States, May--August 2009
25/9: Performance
of Rapid Influenza Diagnostic Tests During Two School Outbreaks of 2009
Pandemic Influenza A (H1N1) Virus Infection --- Connecticut, 2009
11/9:
Oseltamivir-Resistant
2009 Pandemic Influenza A (H1N1) Virus Infection in Two Summer Campers
Receiving Prophylaxis --- North Carolina, 2009
11/9: Receipt
of Influenza Vaccine During Pregnancy Among Women With Live Births ---
Georgia and Rhode Island, 2004--2007
4/9: Surveillance for Pediatric Deaths Associated with 2009 Pandemic Influenza A (H1N1) Virus Infection --- United States, April--August 2009
28/8: 2009 Pandemic Influenza A (H1N1) Virus Infections --- Chicago, Illinois, April--July 2009
28/8: Use of Influenza A (H1N1) 2009 Monovalent Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009
21/8: Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009.
Neurologic Complications Associated with Novel Influenza A (H1N1) Virus Infection in Children --- Dallas, Texas, May 2009
10/7: Intensive-Care Patients With Severe Novel Influenza A (H1N1) Virus Infection --- Michigan, June 2009
19/6: Novel Influenza A (H1N1) Virus Infections Among Health-Care Personnel --- United States, April--May 2009
22/5 Serum Antibody Response to a Novel Influenza A (H1N1) Virus After Vaccination with Seasonal Influenza Vaccine
18/5 Hospitalized Patients with Novel Influenza A (H1N1) Virus Infection -California, April--May, 2009 - DOWNLOAD ISSUE
Quantifying the risk of pandemic influenza in pregnancy and Indigenous people in Australia in 2009 H Kelly
Public
perceptions in relation to intention to receive pandemic influenza
vaccination in a random population sample: evidence from a
cross-sectional telephone survey V Sypsa
Behaviours
regarding preventive measures against pandemic H1N1 influenza among
Italian healthcare workers, October 2009 G La Torre
Behaviour
of the pandemic H1N1 influenza virus in Andalusia, Spain, at the onset
of the 2009-10 season JM Mayoral Cortés,
Prolonged
shedding of influenza A(H1N1)v virus: two case reports from France 2009
H Fleury
Differentiation of two distinct clusters among currently circulating influenza A(H1N1)v viruses, March-September 2009 SR Fereidoun
Oseltamivir-resistant
influenza A(H1N1) viruses detected in Europe during season 2007-8 had
epidemiologic and clinical characteristics similar to co-circulating
susceptible A(H1N1) viruses BC Ciancio.
Pandemic
influenza A(H1N1)v: Human to pig transmission in Norway? M
Hofshagen
Assessing
the impact of the 2009 H1N1 influenza pandemic on reporting of other
threats through the Early Warning and Response System A CoxPandemic
H1N1 influenza lessons from the southern hemisphereby MG Baker, H
Kelly, N Wilson
Preliminary
analysis of the pandemic H1N1 influenza on Réunion Island (Indian
Ocean): surveillance trends (July to mid-September 2009) by F
Thouillot
Progression
and impact of the first winter wave of the 2009 pandemic H1N1 influenza
in New South Wales, Australia by New South Wales public
health network
Pandemic
H1N1 influenza surveillance in Victoria, Australia, April – September,
2009 by JE Fielding,
Early
transmission characteristics of influenza A(H1N1)v in Australia:
Victorian state, 16 May – 3 June 2009 by ES McBryde
The
2009 pandemic H1N1 influenza and indigenous populations of the Americas
and the Pacific by G La Ruche15/10:Use
of an inactivated vaccine in mitigating pandemic influenza A(H1N1)
spread: a modelling study to assess the impact of vaccination timing
and prioritisation strategies
by V Sypsa, I Pavlopoulou, A Hatzakis
15/10:Pandemic
H1N1 influenza: predicting the course of a pandemic and assessing the
efficacy of the planned vaccination programme in the United States by S Towers, Z Feng
15/10:Pandemic influenza A(H1N1) 2009 vaccines in the European Union
by K Johansen, A Nicoll, BC Ciancio, P Kramarz
8/10:Does viral interference affect spread of influenza? A Linde
8/10: Google Flu Trends includes 14 European countries. Eurosurveillance editorial team
:Residual immunity in older people against the influenza A(H1N1) – recent experience in northern Spain. E Pérez-Trallero
: Early
estimates of 2009 pandemic influenza A(H1N1) virus activity in general
practice in France: incidence of influenza-like illness and age
distribution of reported cases. C Turbelin
24/9:Enhanced
surveillance of initial cases of pandemic H1N1 2009 influenza in
Ireland, April - July 2009.
Oseltamivir
susceptibility in south-western France during the 2007-8 and 2008-9
influenza epidemics and the ongoing influenza pandemic 2009 S Burrel
17/9: Sub-optimal
hand sanitiser usage in a hospital entrance during an influenza
pandemic, New Zealand, August 2009
17/9: Economic
consequences to society of pandemic H1N1 influenza 2009 – preliminary
results for Sweden
3/9:Assessment of secondary attack rate and effectiveness of antiviral prophylaxis among household contacts in an influenza A(H1N1)v outbreak in Kobe, Japan, May–June 2009
3/9:Epidemiological analysis of the influenza A(H1N1)v outbreak in Bolivia, May-August 2009
27/8:Influenza A(H1N1)v in Germany: the first 10,000 cases.
27/8:Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009.
13/8:Epidemiological and transmissibility analysis of influenza A(H1N1)v in a southern hemisphere setting: Peru.
13/8:What will the next influenza season bring about: seasonal influenza or the new A(H1N1)v? An analysis of German influenza surveillance data.
6/8: Description of the early stage of pandemic (H1N1) 2009 in Germany, 27 April-16 June 2009. Novel influenza A(H1N1) investigation team
13/8: Public health preparedness for two mass gathering events in the context of pandemic influenza (H1N1) 2009 - Serbia, July 2009.
13/8: Community transmission of influenza A (H1N1)v virus at a rock festival in Belgium, 2-5 July 2009.
Modified surveillance of influenza A(H1N1)v virus infections in France. Influenza A(H1N1)v investigation teams
Clinical features of cases of influenza A (H1N1)v in Osaka prefecture, Japan, May 2009 .
Europe’s initial experience with pandemic (H1N1) 2009 - mitigation and delaying policies and practices .
Epidemiology and control of influenza A(H1N1)v in the Netherlands: the first 115 cases by S Hahné, et al.
Enhanced epidemiological surveillance of influenza A(H1N1)v in Italy
An outbreak of influenza A(H1N1)v in a boarding school in South East England, May-June 2009 ..
Preliminary descriptive epidemiology of a large school outbreak of influenza A(H1N1)v in the West Midlands, United Kingdom, May 2009 .
Outbreak of influenza A(H1N1)v without travel history in a school in the Toulouse district, France, June 2009 .A Guinard
StatFlu - a static modelling tool for pandemic influenza hospital load for decision makers
Modelling of the influenza A(H1N1)v outbreak in Mexico City, April-May 2009, with control sanitary measures.
The emerging influenza pandemic: estimating the case fatality ratio
Influenza A(H1N1)v in the southern hemisphere - lessons to learn for Europe?..
Virological surveillance of human cases of influenza A(H1N1)v virus in Italy: preliminary results
Epidemiology of influenza A(H1N1)v virus infection in Japan, May - June 2009.
School closure is currently the main strategy to mitigate influenza A(H1N1)v: a modeling study
A variety of respiratory viruses found in symptomatic travellers returning from countries with ongoing spread of the new influenza A(H1N1)v virus strain
Preliminary analysis of influenza A(H1N1)v individual and aggregated case reports from EU and EFTA countries by ECDC working group on influenza A(H1N1)v
Enhanced influenza surveillance on Réunion Island (southern hemisphere) in the context of the emergence of influenza A(H1N1)v by E D’Ortenzio, et al.
Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan
Epidemiology of new influenza A (H1N1) virus infection, United Kingdom, April – June 2009
Evaluation of four real-time PCR assays for detection of influenza A(H1N1)v viruses.
Origins of the new influenza A(H1N1) virus: time to take action
Norwegians approve of the health authorities’ strategy to communicate worst case pandemic scenarios
Cluster of new influenza A(H1N1) cases in travellers returning from Scotland to Greece – community transmission within the European Union?
New influenza A(H1N1) virus infections in France, April – May 2009 by New influenza A(H1N1) investigation teams
Cluster analysis of the origins of the new influenza A(H1N1) virus
Influenza A(H5N1): an overview of the current situation
Why are Mexican data important?
New influenza A(H1N1) virus infections in Spain, April-May 2009
Epidemiology of new influenza A(H1N1) in the United Kingdom, April – May 2009
A preliminary estimation of the reproduction ratio for new influenza A(H1N1) from the outbreak in Mexico, March-April 2009 by PY Boëlle, P Bernillon, JC Desenclos
Clinical
Features of the Initial Cases of 2009 Pandemic Influenza A (H1N1) Virus
Infection in China. Bin Cao
When
to Consider the Use of Antibiotics in the Treatment of 2009 H1N1
Influenza-Associated Pneumonia. Wright PF
Australia's
Winter with the 2009 Pandemic Influenza A (H1N1) Virus. Bishop JF
Antiviral Treatment for Patients Hospitalized with 2009 Pandemic Influenza A (H1N1) Tim Uyeki
Emergence
of
Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis M Baz
Older
Age and a
Reduced Likelihood of 2009 H1N1 Virus Infection D.N. Fisman
Pathological Changes Associated with the 2009
H1N1 Virus M.V.
Soto-Abraham
NEJM: A Novel Influenza A (H1N1) Vaccine in Various Age Groups. Feng-Cai Zhu
NEJM Use of Ribavirin to Treat Influenza. Chan-Tack KM
8/10: Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand. The ANZIC Influenza Investigators
8/10: Hospitalized Patients with 2009 H1N1 Influenza in the United States, April–June 2009. Seema Jain,
30/9Novel H1N1 Influenza and Respiratory Protection for Health Care Workers. Shine KI .
24/9: Comparative
Efficacy of Inactivated and Live Attenuated Influenza Vaccines
Arnold S. Monto
17/9: Poverty, Wealth, and Access to Pandemic Influenza Vaccines T. Yamada
10/9: Response
after One Dose of a Monovalent Influenza A (H1N1) 2009 Vaccine —
Preliminary Report Greenberg
10/9:Trial of
Influenza A (H1N1) 2009 Monovalent MF59-Adjuvanted Vaccine —
Preliminary Report T.W. Clark
10/9:Cross-Reactive
Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus K.
Hancock and Others
10/9 EDITORIAL: Pandemic
Influenza Vaccine Policy — Considering the Early Evidence K.M.
Neuzil
Severe Respiratory Disease Concurrent with the Circulation of H1N1 Influenza G. Chowell and Others Full Text
Pneumonia and Respiratory Failure from Swine-Origin Influenza A (H1N1) in MexicoR. Perez-Padilla and Others Full Text
Historical Perspective — Emergence of Influenza A (H1N1) Viruses S.M. Zimmer and D.S. Burke Full Text
The Persistent Legacy of the 1918 Influenza Virus D.M. Morens, J.K. Taubenberger, and A.S. Fauci Full Text
Spread of a Novel Influenza A (H1N1) Virus via Global Airline Transportation K. Khan and Others Full Text
Rapid-Test Sensitivity for Novel Swine-Origin Influenza A (H1N1) Virus in Humans D.J. Faix, S.S. Sherman, and S.H. Waterman Full Text
Managing and Reducing Uncertainty in an Emerging Influenza Pandemic M. Lipsitch and Others Full Text
Geographic Dependence, Surveillance, and Origins of the 2009 Influenza A (H1N1) Virus V. Trifonov, H. Khiabanian, and R. Rabadan Full Text
Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team Full Text
Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005–2009 V. Shinde and Others Full Text
H1N1 Influenza A Disease — Information for Health Professionals L.R. Baden and Others Full Text
Implications of the Emergence of a Novel H1 Influenza Virus R.B. Belshe Full Text
Digital Disease Detection — Harnessing the Web for Public Health Surveillance J.S. Brownstein, C.C. Freifeld, and L.C. Madoff Full Text
Influenza A (H1N1) Virus, 2009 — Online Monitoring J.S. Brownstein, C.C. Freifeld, and L.C. Madoff Full Text The Signature Features of Influenza Pandemics — Implications for Policy M.A. Miller and Others Full Text
Safety
and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when
administered alone or simultaneously with the seasonal influenza
vaccine for the 2009-10 influenza season: a multicentre, randomised
controlled trial. Vajo Z
Immune
response after a single vaccination against 2009 influenza A H1N1 in
USA: a preliminary report of two randomised controlled phase 2 trials. Plennevaux E
Safety
and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China:
a multicentre, double-blind, randomised, placebo-controlled trial.Liang XF
stablishment of public health security in Saudi Arabia for the 2009
Hajj in response to pandemic influenza A H1N1. Memish Z
Infection
and death from influenza A H1N1 virus in Mexico: a retrospective
analysis Santiago Echevarría-Zuno
Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines.Black
S
Lancet 19/9: H1N1 pneumonitis treated with intravenous zanamivir Michael Kidd
Lancet 22/8: Swine-origin influenza virus H1N1, seasonal influenza virus, and critical illness in children
Lancet 8/8: H1N1 2009 influenza virus infection during pregnancy in the USA.
Lancet ID aout: Economics of stockpiling for an influenza pandemic Dhankhar PView PDF
Lancet ID aout: Influenza in the tropics Leo Y-S View PDF
Lancet ID aout: Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses Kunisaki KM View PDF
Lancet ID aout: Closure of schools during an influenza pandemic Cauchemez S View PDF
H1N1 2009 influenza virus infection during pregnancy in the USA The Lancet, Denise J Jamieson, et al
Possible origin of current influenza A H1N1 viruses Hong Zhang, Ling Chen
Influenza in the tropics Yee-Sin Leo, David C Lye, Angela Chow
Economics of stockpiling for an influenza pandemic Praveen Dhankhar, Erik J Dasbach, Elamin H Elbasha
Reacting to the emergence of swine-origin influenza A H1N1 Catherine WM Ong, Khek Yu Ho, Li Yang Hsu, Aymeric YT Lim, Dale A Fisher, Paul A Tambyah
Putting influenza A H1N1 in its place - Lancet Infectious Diseases Jun 2009 Vol. 9 No. 6 p 331 View PDF
Preparation for a pandemic: influenza A H1N1 Shetty, P Lancet Infectious Diseases Jun 2009 Vol. 9 No. 6 pp 339-340 View PDF
21 August 2009, vol. 84, 34 (pp 341–348) Mathematical modelling of the pandemic H1N1 2009
26/6: New influenza A (H1N1) virus: WHO guidance on public health measures, 11 June 2009 :: full text [pdf 267kb]
19 juin: New influenza A (H1N1) virus: global epidemiological situation, June 2009 Download full text [pdf 407kb]
12 juin: Human infection with new influenza A (H1N1) virus: clinical observations from a school-associated outbreak in Kobe, Japan, May 2009 : Download full text [pdf 518kb]
BEH-Web 01/2009. Chronique d'un début de pandémie. Cas d'infection par le nouveau virus de la grippe A(H1N1)v en France, situation au 5 juin 2009
VoozaFlu : un outil au service de la surveillance de la nouvelle grippe A(H1N1)v
Le point sur les paramètres épidémiologiques dans l’épidémie due au nouveau virus de la grippe A(H1N1)v .
Adaptation du dispositif de surveillance à la situation épidémiologique
Manifestations cliniques observées dans les premières séries de cas de grippe due au virus émergent Influenza A(H1N1)v
Grippe A(H1N1)v : naissance d’une pandémie - Bilan mondial au 5 juin 2009
Le point sur le virus de la nouvelle grippe A(H1N1)v
